(NASDAQ: PRE) Prenetics Global's forecast annual revenue growth rate of 87.51% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.8%, and it is also forecast to beat the US market's average forecast revenue growth rate of 15.8%.
Prenetics Global's revenue in 2026 is $107,762,000.On average, 6 Wall Street analysts forecast PRE's revenue for 2026 to be $3,671,802,541, with the lowest PRE revenue forecast at $3,162,155,465, and the highest PRE revenue forecast at $3,993,452,511. On average, 6 Wall Street analysts forecast PRE's revenue for 2027 to be $6,187,431,376, with the lowest PRE revenue forecast at $4,869,413,730, and the highest PRE revenue forecast at $7,337,831,006.
In 2028, PRE is forecast to generate $9,691,106,424 in revenue, with the lowest revenue forecast at $9,403,251,778 and the highest revenue forecast at $10,074,912,619.